FDA approves teprotumumab for thyroid eye disease

The FDA on Tuesday approved the human monoclonal antibody teprotumumab for the treatment of adults with thyroid eye disease, marking the first drug approved for the condition, according to an agency press release.
“This is a great announcement for all the patients and families affected by thyroid eye disease,” Raymond Douglas, MD, PhD, director of the orbital and thyroid eye disease program at Cedars-Sinai Medical Center, told Healio. “For the first time, there is an FDA-approved medication shown to reverse this terrible disease. We appreciate all the efforts of the (Read more...)

Full Story →